Predicting outcome in melanoma: where are we now?

被引:29
作者
Jennings, L. [1 ]
Murphy, G. M. [1 ]
机构
[1] Beaumont Hosp, Dept Dermatol, Dublin 9, Ireland
关键词
melanoma; prognosis; staging; survival; POLYMERASE-CHAIN-REACTION; SENTINEL-NODE BIOPSY; PRIMARY CUTANEOUS MELANOMA; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; TUMOR-INFILTRATING LYMPHOCYTES; SERUM LACTATE-DEHYDROGENASE; ADVANCED MALIGNANT-MELANOMA; MONOCLONAL-ANTIBODY D2-40; AMERICAN JOINT COMMITTEE; EARLY-STAGE MELANOMA;
D O I
10.1111/j.1365-2133.2009.09324.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Melanoma incidence continues to rise in most countries. This is of grave concern, given the mortality rate in a relatively young population. Current staging tools are limited in their ability to predict accurately those at risk of metastatic disease, relapse and treatment failure. This overview comprehensively reviews relevant literature, with the focus on the last 5 years, and discusses the current state of traditional and emerging novel methods of staging for melanoma and their effect on prognosis in this population.
引用
收藏
页码:496 / 503
页数:8
相关论文
共 100 条
  • [1] Prognostic value of serum S-100B in malignant melanoma
    Andrés, R
    Mayordomo, JI
    Zaballos, P
    Rodino, J
    Isla, D
    Escudero, P
    Elosegui, L
    Filipovich, E
    Saenz, A
    Polo, E
    Tres, A
    [J]. TUMORI JOURNAL, 2004, 90 (06): : 607 - 610
  • [2] Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas
    Ashida, Atsuko
    Takata, Minoru
    Murata, Hiroshi
    Kido, Kenji
    Saida, Toshiaki
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (04) : 862 - 868
  • [3] Auge JM, 2005, ANTICANCER RES, V25, P1779
  • [4] Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis
    Bafounta, ML
    Beauchet, A
    Chagnon, S
    Saiag, P
    [J]. LANCET ONCOLOGY, 2004, 5 (11) : 673 - 680
  • [5] Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system
    Balch, CM
    Soong, SJ
    Gershenwald, JE
    Thompson, JF
    Reintgen, DS
    Cascinelli, N
    Urist, M
    McMasters, KM
    Ross, MI
    Kirkwood, JM
    Atkins, MB
    Thompson, JA
    Coit, DG
    Byrd, D
    Desmond, R
    Zhang, YT
    Liu, PY
    Lyman, GH
    Morabito, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) : 3622 - 3634
  • [6] Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma
    Balch, CM
    Buzaid, AC
    Soong, SJ
    Atkins, MB
    Cascinelli, N
    Coit, DG
    Fleming, ID
    Gershenwald, JE
    Houghton, A
    Kirkwood, JM
    McMasters, KM
    Mihm, MF
    Morton, DL
    Reintgen, DS
    Ross, MI
    Sober, A
    Thompson, JA
    Thompson, JF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) : 3635 - 3648
  • [7] Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma
    Blaheta, HJ
    Ellwanger, U
    Schittek, B
    Sotlar, K
    Maczey, E
    Breuninger, H
    Thelen, MH
    Bueltmann, B
    Rassner, G
    Garbe, C
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (04) : 637 - 642
  • [8] BOGDAHN U, 1989, CANCER RES, V49, P5358
  • [9] Five-year results of prognostic value of tyrosinase in peripheral blood of uveal melanoma patients
    Boldin, I
    Langmann, G
    Richtig, E
    Schwantzer, G
    Ardjomand, N
    Wegscheider, B
    El-Shabrawi, Y
    [J]. MELANOMA RESEARCH, 2005, 15 (06) : 503 - 507
  • [10] The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma
    Bonfrer, JMG
    Korse, CM
    Nieweg, OE
    Rankin, EM
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (12) : 2210 - 2214